Osteoporosis | QS149 | | |
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine | TA440 | | |
Ixekizumab for treating moderate to severe plaque psoriasis | TA442 | | |
Obeticholic acid for treating primary biliary cholangitis | TA443 | | |
VAAFT for treating anal fistulae | MIB102 | | |
Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
Alcohol-use disorders: diagnosis and management of physical complications | CG100 | | |
Sexually transmitted infections: condom distribution schemes | NG68 | | |
Minimally invasive sacroiliac joint fusion surgery for chronic sacroiliac pain | IPG578 | | |
Irritable bowel syndrome in adults: diagnosis and management | CG61 | | |
Managing medicines for adults receiving social care in the community | NG67 | | |
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) | TA240 | | |
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal) | TA438 | | |
Mitochondrial disorders in children: Co-enzyme Q10 | ES11 | | |
Mollii suit for spasticity | MIB100 | | |
Bair Hugger for measuring core temperature during perioperative care | MIB99 | | |
Patient group directions | MPG2 | | |
Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women | IPG576 | | |
Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapse | IPG577 | | |
Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal) | TA436 | | |
Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal) | TA437 | | |
Elotuzumab for previously treated multiple myeloma (terminated appraisal) | TA434 | | |
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal) | TA435 | | |
Hyperhidrosis: oxybutynin | ES10 | | |
Mental health of adults in contact with the criminal justice system | NG66 | | |
Narcolepsy with or without cataplexy in adults: pitolisant | ES8 | | |
Skin involvement in systemic sclerosis: rituximab | ES7 | | |
TopClosure Tension Relief System for wound closure | MIB97 | | |
SimpliCT laser-guided needle placement in interventional radiology | MIB98 | | |
Head and neck cancer | QS146 | | |
Healthy workplaces: improving employee mental and physical health and wellbeing | QS147 | | |
Community engagement: improving health and wellbeing | QS148 | | |
Ustekinumab for treating active psoriatic arthritis | TA340 | | |
Ustekinumab for the treatment of adults with moderate to severe psoriasis | TA180 | | |
Care of dying adults in the last days of life | QS144 | | |
Intrapartum care | QS105 | | |
Molecular testing strategies for Lynch syndrome in people with colorectal cancer | DG27 | | |
Migalastat for treating Fabry disease | HST4 | | |
Lateral interbody fusion in the lumbar spine for low back pain | IPG574 | | |
Trabecular stent bypass microsurgery for open-angle glaucoma | IPG575 | | |
Drug misuse prevention: targeted interventions | NG64 | | |
Everolimus for advanced renal cell carcinoma after previous treatment | TA432 | | |
Apremilast for treating active psoriatic arthritis | TA433 | | |
Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide | ES5 | | |
Smart One for measuring lung function | MIB96 | | |
U-Drain for people needing night drainage of urine or dialysis fluid | MIB95 | | |
Menopause | QS143 | | |
HumiGard for preventing inadvertent perioperative hypothermia | MTG31 | | |
Osteoporosis: assessing the risk of fragility fracture | CG146 | | |
eazyplex SuperBug kits for detecting carbapenemase-producing organisms | MIB94 | | |
Stable angina | QS21 | | |
Falls in older people | QS86 | | |
Cerebral palsy in under 25s: assessment and management | NG62 | | |
Antimicrobial stewardship: changing risk-related behaviours in the general population | NG63 | | |
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation | TA429 | | |
Sofosbuvir–velpatasvir for treating chronic hepatitis C | TA430 | | |
CentriMag for heart failure | MIB92 | | |
Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis | MIB93 | | |
Boston Keratoprosthesis Type I for corneal blindness | MIB91 | | |
Refractory extrapulmonary sarcoidosis: infliximab | ES4 | | |
Smartinhaler for asthma | MIB90 | | |
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib | TA427 | | |
Tuberculosis | QS141 | | |
Learning disability: identifying and managing mental health problems | QS142 | | |
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation | CG135 | | |
Extracorporeal shockwave therapy for Achilles tendinopathy | IPG571 | | |
Radiation therapy for early Dupuytren's disease | IPG573 | | |
Everolimus with exemestane for treating advanced breast cancer after endocrine therapy | TA421 | | |
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer | TA422 | | |
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens | TA423 | | |
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer | TA424 | | |
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia | TA425 | | |
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia | TA426 | | |
Pulmonary sarcoidosis: infliximab | ES2 | | |
Blood transfusion | QS138 | | |
Oral health promotion in the community | QS139 | | |
Hypothermia: prevention and management in adults having surgery | CG65 | | |
Epiduroscopic lumbar discectomy through the sacral hiatus for sciatica | IPG570 | | |
Ticagrelor for preventing atherothrombotic events after myocardial infarction | TA420 | | |
XprESS multi sinus dilation system for treating chronic sinusitis | MTG30 | | |
CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubes | MIB48 | | |
Mental wellbeing and independence for older people | QS137 | | |
HIV testing: increasing uptake among people who may have undiagnosed HIV | NG60 | | |
Transition between inpatient hospital settings and community or care home settings for adults with social care needs | QS136 | | |
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis | CG95 | | |
Coexisting severe mental illness and substance misuse: community health and social care services | NG58 | | |
Spasticity in under 19s: management | CG145 | | |
OCS Heart system for heart transplant | MIB86 | | |
CytoSorb therapy for sepsis | MIB87 | | |
Sternal Talon for sternal closure in cardiothoracic surgery | MIB88 | | |
Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions | MIB89 | | |
Endoscopic transluminal pancreatic necrosectomy | IPG567 | | |
Percutaneous insertion of craniocaudal expandable implants for vertebral compression fracture | IPG568 | | |
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity | IPG569 | | |
Dapagliflozin in combination therapy for treating type 2 diabetes | TA288 | | |
Nivolumab for previously treated advanced renal cell carcinoma | TA417 | | |
Dapagliflozin in triple therapy for treating type 2 diabetes | TA418 | | |
Apremilast for treating moderate to severe plaque psoriasis | TA419 | | |
High-throughput non-invasive prenatal testing for fetal RHD genotype | DG25 | | |
Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab | ES1 | | |
Physical health of people in prison | NG57 | | |
Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
Needle-free arterial non-injectable connector | MIB85 | | |
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor | TA415 | | |
Elbasvir–grazoprevir for treating chronic hepatitis C | TA413 | | |
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma | TA414 | | |
Coeliac disease | QS134 | | |
Single-incision short sling mesh insertion for stress urinary incontinence in women | IPG566 | | |
Children's attachment | QS133 | | |
Woundchek Protease Status for assessing elevated protease status in chronic wounds | MIB83 | | |
Miniature lens system implantation for advanced age-related macular degeneration | IPG565 | | |
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer | TA411 | | |
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases | TA412 | | |
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer | TA406 | | |
Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors | TA407 | | |
Pegaspargase for treating acute lymphoblastic leukaemia | TA408 | | |
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion | TA409 | | |
Talimogene laherparepvec for treating unresectable metastatic melanoma | TA410 | | |
Multimorbidity: clinical assessment and management | NG56 | | |
Intravenous fluid therapy in children and young people in hospital | QS131 | | |
Social care for older people with multiple long-term conditions | QS132 | | |
Harmful sexual behaviour among children and young people | NG55 | | |
QuikRead go for C-reactive protein testing in primary care | MIB78 | | |
FLEXISEQ for osteoarthritis | MIB80 | | |
Alere Afinion CRP for C-reactive protein testing in primary care | MIB81 | | |
Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
Contraception | QS129 | | |
Transition between inpatient mental health settings and community or care home settings | NG53 | | |
Stable angina: management | CG126 | | |
Acute upper gastrointestinal bleeding in over 16s: management | CG141 | | |
Axxent electronic brachytherapy system for early stage breast cancer | MIB76 | | |
OSNA for colon cancer staging | MIB77 | | |
Bosutinib for previously treated chronic myeloid leukaemia | TA401 | | |
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin | TA402 | | |
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer | TA403 | | |
Degarelix for treating advanced hormone-dependent prostate cancer | TA404 | | |
Trifluridine–tipiracil for previously treated metastatic colorectal cancer | TA405 | | |
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel | TA391 | | |
Early years: promoting health and wellbeing in under 5s | QS128 | | |
Obesity: clinical assessment and management | QS127 | | |
Palliative care for adults: strong opioids for pain relief | CG140 | | |
Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation | IPG563 | | |
Motor neurone disease | QS126 | | |
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen | TA259 | | |
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation | TA398 | | |
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts | TA399 | | |
Nivolumab in combination with ipilimumab for treating advanced melanoma | TA400 | | |
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated | TA387 | | |
QTUG for assessing falls risk and frailty | MIB73 | | |
Stretta System for gastro-oesophageal reflux disease | MIB74 | | |
Non-Hodgkin's lymphoma: diagnosis and management | NG52 | | |
Alair bronchial thermoplasty system for adults with severe difficult to control asthma | MIB71 | | |
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | CG64 | | |
Non-alcoholic fatty liver disease (NAFLD): assessment and management | NG49 | | |
Oral health for adults in care homes | NG48 | | |
Cellvizio confocal endomicroscopy system for characterising pancreatic cysts | MIB69 | | |
Mobi-C for cervical disc replacement | MIB70 | | |
Microstructural scaffold (patch) insertion without autologous cell implantation for repairing symptomatic chondral knee defects | IPG560 | | |
Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting | IPG561 | | |
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules | IPG562 | | |
Bronchiolitis in children | QS122 | | |
Home care for older people | QS123 | | |
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | TA393 | | |
Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | TA394 | | |
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer | TA395 | | |
Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma | TA396 | | |
Adalimumab for treating moderate to severe hidradenitis suppurativa | TA392 | | |
Breast cancer | QS12 | | |
S-Cath System for suprapubic catheterisation | MIB68 | | |
Complicated urinary tract infections: ceftolozane/tazobactam | ESNM74 | | |
Complicated intra-abdominal infections: ceftolozane/tazobactam | ESNM75 | | |
Endovenous mechanochemical ablation for varicose veins | IPG557 | | |
Haematological cancers: improving outcomes | NG47 | | |
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes | TA390 | | |
Reversal of the anticoagulant effect of dabigatran: idarucizumab | ESNM73 | | |
CareLink network service for remote monitoring of people with cardiac devices | MIB64 | | |
Prolaris gene expression assay for assessing long-term risk of prostate cancer progression | MIB65 | | |
Secca System for faecal incontinence | MIB66 | | |
LATITUDE NXT Patient Management System for monitoring cardiac devices at home | MIB67 | | |
ImmunoCAP ISAC 112 for multiplex allergen testing | DG24 | | |
Microwave ablation for treating liver metastases | IPG553 | | |
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension | IPG554 | | |
Percutaneous interlaminar endoscopic lumbar discectomy for sciatica | IPG555 | | |
Percutaneous transforaminal endoscopic lumbar discectomy for sciatica | IPG556 | | |
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction | TA388 | | |
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer | TA389 | | |
Antimicrobial stewardship | QS121 | | |
Controlled drugs: safe use and management | NG46 | | |
Stroke in adults | QS2 | | |
Routine preoperative tests for elective surgery | NG45 | | |